The Sickle Cell Disease Association of America is extending efforts to increase and diversify participation rates of underrepresented demographics in clinical trials through their C.A.R.E.S. Consortium initiative.
The Sickle Cell Disease Association of America is extending efforts to increase and diversify participation rates of underrepresented demographics in clinical trials through their C.A.R.E.S. Consortium initiative.
